Home › Targets › APRIL
APRIL (4 companies · 11 programs)
Companies with an active program directed at APRIL.
- atacicept — IgA Nephropathy NDA Submitted
- atacicept — Primary Membranous Nephropathy Phase 2
- atacicept — Focal Segmental Glomerulosclerosis Phase 2
- atacicept — Minimal Change Disease Phase 2
- VT-109 Preclinical
- VT-109 Preclinical
- atacicept — Membranous Nephropathy Phase 2
- telitacicept — Generalized Myasthenia Gravis Phase 3
- telitacicept — Sjögren's Disease Phase 3
- CLYM116 — IgA Nephropathy Phase 1
- JADE101 — IgA Nephropathy Phase 1
